HSB 160 requires Iowa physicians to discuss specific risks and alternatives before prescribing opioid pain medications for acute or chronic pain, both for the initial prescription and the third prescription in a treatment course. Doctors must cover addiction risks, dangers of mixing opioids with alcohol/benzodiazepines, necessity of the prescription, and alternative treatments, then document this discussion in the patient’s medical record. The law excludes prescriptions for terminal illness comfort care (like hospice) or medications treating substance use disorders. It directly affects physicians prescribing opioids and their patients, aiming to improve informed consent around high-risk medications. The bill amends existing medical practice standards to mandate these patient discussions.
SSB 1146 (now renumbered as SF 470) establishes new rules for dental insurance in Iowa, affecting dental providers, insurance companies (dental carriers), and patients. It requires dental carriers to reimburse providers for services approved via prior authorization (with exceptions like exceeded benefit limits or documentation issues), and mandates that carriers notify providers if a patient's plan is state-regulated - via online portals or "state-regulated" labels on ID cards starting in 2025. The bill also limits dental carriers' ability to recover overpayments, requiring written notice within 365 days of payment and providing providers with appeal options for disputed claims. These changes aim to clarify billing processes and ensure transparency in dental coverage.
HF 699 clarifies that certain drug-checking tools and materials are not considered "drug paraphernalia" under Iowa law. It specifically exempts fentanyl/xylazine test strips, drug-checking equipment, and related materials used by harm reduction organizations for testing substances. The bill protects individuals and organizations from criminal charges, civil penalties, or loss of housing for using these tools or conducting drug checks. It also allows state funds, including opioid settlement money, to support these harm reduction activities.
HSB 327 allocates federal block grant funds for Iowa's health programs, primarily directing them to the Department of Health and Human Services for substance abuse treatment, community mental health services, maternal/child health, and preventive health. The bill specifies exact annual funding amounts (e.g., $14.1 million for substance abuse treatment annually) and mandates that at least 20% of substance abuse funds support prevention programs. It requires strict spending rules, including limits on administrative costs (5% for substance abuse, 5% for mental health, 10% for maternal health) and minimum funding levels for services for pregnant women and children. The bill also prohibits using maternal health funds for indirect costs at the University of Iowa and requires coordination between health agencies to improve care for low-income women and children.
Senate File 649 is a legislative bill that appropriates state funds for the fiscal year beginning July 1, 2025. It allocates money to the Department of Veterans Affairs for administration, the Iowa Veterans Home, and a home ownership assistance program for eligible service members. The bill also provides funding to the Department of Health and Human Services for aging and disability services, including programs for older adults and individuals with disabilities. Additionally, it appropriates funds for behavioral health initiatives, such as prevention, treatment, and recovery efforts for substance use and problem gambling, impacting individuals and families across the state. These appropriations support various public health programs and services.
This bill establishes how Iowa's opioid settlement fund will be managed and used to address the opioid crisis, impacting state agencies, healthcare providers, and Iowans needing treatment. It mandates that the Department of Health and Human Services (HHS) and the Attorney General (AG) annually propose appropriations, with 75% of available funds going to HHS and 25% to the AG, and requires regular reports on disbursements. For fiscal year 2024-2025, the bill appropriates $12 million to HHS for grants to specific nonprofit organizations to expand a nature-based recovery campus, and an additional $30 million to HHS for general opioid crisis abatement efforts. These funds aim to support treatment, prevention, and recovery services for substance use and co-occurring mental health disorders.
HF 1038 allocates funds from Iowa's opioid settlement to state agencies addressing the opioid crisis, directly affecting programs that provide treatment, prevention, and recovery services. The bill specifies how the money is distributed (disbursed) to eligible state entities and includes rules for when the funding takes effect, including retroactive application for prior periods. It does not change eligibility for the settlement funds but establishes the legal framework for their use. The bill passed unanimously and was signed into law by the Governor on June 6, 2025.
This bill allows physician assistants (PAs) and advanced registered nurse practitioners (ARNPs) to testify at Iowa's involuntary commitment hearings for mental health or substance abuse cases, on behalf of licensed physicians or mental health professionals who examined the person. It requires courts to review specific sworn statements confirming the PA/ARNP witnessed the exam, reviewed the written report, and the original examiner cannot attend. The law expands who can provide testimony at these hearings, directly affecting PAs, ARNPs, and the court process for commitment cases. It does not change who must be examined but adds a new pathway for testimony when the primary examiner is unavailable.
This bill requires Medicaid plans and health carriers to treat nonopioid pain medications approved by the FDA equally with opioid drugs in coverage decisions. Specifically, nonopioid drugs cannot be labeled as "nonpreferred" if opioids are preferred, and must face no stricter coverage requirements (like prior authorization) than opioids. Health carriers must also create and submit "pain management access plans" covering at least two non-opioid prescription medications and three non-drug pain treatments (e.g., physical therapy), ensuring these options aren’t blocked by excessive barriers. The rules apply immediately upon FDA approval of a nonopioid drug, bypassing standard committee review for inclusion on preferred drug lists. This directly affects Medicaid managed care organizations and health insurance providers in Iowa.
This bill requires Medicaid and health insurers to treat nonopioid pain medications equally with opioids in coverage. It prohibits designating nonopioid drugs as "nonpreferred" when opioids are preferred and bans stricter prior authorization or step therapy requirements for nonopioid drugs compared to opioids. Health insurers must develop a "pain management access plan" covering at least two FDA-approved non-opioid prescription medications (not controlled substances) and three non-drug pain treatments, without more restrictive rules for nonopioid options. The bill applies immediately upon FDA approval of a nonopioid pain drug, regardless of prior committee review. It affects Medicaid managed care organizations and health carriers offering coverage in Iowa.